CHINA PHARMA HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $14.99M.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $2.45M.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.36M.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2025 was $17.92M, a 384.88% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2024 was $3.69M, a 123.94% increase from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2023 was $1.65M.
- CHINA PHARMA HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2010 was $2.58M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $14.99M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $17.92M 10-K · filed 2026-04-01 | |
| 2025-09-30 | $2.45M 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $3.69M 10-K · filed 2026-04-01 | |
| 2024-03-31 | $1.36M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $1.65M 10-K · filed 2025-03-31 | |
| 2010-12-31 | $2.58M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |